Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 17 | $9.25 | $10.72 | $10.24 |
| Q2 2026 | 16 | $1.88 | $9.28 | $7.27 |
| Q3 2026 | 16 | -$1.32 | $0.04 | -$0.95 |
| Q4 2026 | 15 | -$11.10 | -$4.93 | -$7.87 |
| Q1 2027 | 6 | $12.10 | $12.45 | $12.28 |
| Q2 2027 | 6 | $8.86 | $9.12 | $8.99 |
| Q3 2027 | 6 | $1.24 | $1.28 | $1.26 |
| Q4 2027 | 6 | -$5.66 | -$5.50 | -$5.58 |
| Q1 2028 | 14 | $15.00 | $15.44 | $15.23 |
| Q2 2028 | 14 | $11.44 | $11.78 | $11.62 |
| Q3 2028 | 14 | $4.01 | $4.12 | $4.07 |
| Q4 2028 | 14 | -$3.11 | -$3.02 | -$3.07 |
Humana Inc. last posted its earnings results on Wednesday, July 29th, 2026. The company reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The company had revenue of 40.87 B for the quarter and had revenue of 129.66 B for the year. Humana Inc. has generated $10 earnings per share over the last year ($9.84 diluted earnings per share) and currently has a price-to-earnings ratio of 35.57. Humana Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/29/2026 | Q2 2026 | $7.27 | $5.79 | -1.48 | $40.58 B | $40.87 B |
| 04/29/2026 | Q1 2026 | $10.24 | $9.85 | -0.39 | $39.37 B | $39.65 B |
| 02/19/2026 | Q4 2025 | N/A | -$6.61 | N/A | $32.04 B | $32.52 B |
| 11/05/2025 | Q3 2025 | $2.93 | $1.62 | -1.31 | $32.00 B | $32.65 B |
| 07/30/2025 | Q2 2025 | $5.92 | $4.52 | -1.4 | $31.87 B | $32.39 B |
| 04/30/2025 | Q1 2025 | $10.07 | $10.31 | 0.24 | $32.20 B | $32.11 B |
| 02/20/2025 | Q4 2024 | N/A | -$5.75 | N/A | $28.81 B | $29.21 B |
| 10/30/2024 | Q3 2024 | $3.40 | $3.99 | 0.59 | $28.68 B | $29.40 B |
| 07/31/2024 | Q2 2024 | $5.85 | $5.64 | -0.21 | $28.52 B | $29.54 B |
| 04/24/2024 | Q1 2024 | $6.12 | $6.13 | 0.01 | $28.52 B | $29.61 B |
| 02/15/2024 | Q4 2023 | N/A | -$4.42 | N/A | $25.51 B | $26.46 B |
| 11/01/2023 | Q3 2023 | $7.16 | $6.74 | -0.42 | $25.57 B | $26.42 B |
| 08/02/2023 | Q2 2023 | $8.82 | $7.70 | -1.12 | $25.83 B | $26.75 B |
| 04/26/2023 | Q1 2023 | $9.27 | $9.91 | 0.64 | $26.43 B | $26.74 B |
| 02/16/2023 | Q4 2022 | N/A | -$0.12 | N/A | $22.48 B | $22.44 B |
| 11/02/2022 | Q3 2022 | $6.28 | $9.44 | 3.16 | $22.82 B | $22.80 B |
| 07/27/2022 | Q2 2022 | $7.67 | $5.50 | -2.17 | $23.45 B | $23.66 B |
| 04/27/2022 | Q1 2022 | $6.78 | $7.32 | 0.54 | $23.54 B | $23.97 B |
| 02/17/2022 | Q4 2021 | N/A | -$0.11 | N/A | $21.22 B | $21.02 B |
| 11/03/2021 | Q3 2021 | $4.61 | $11.91 | 7.3 | $20.90 B | $21.76 B |
In the previous quarter, Humana Inc. (:HUM) reported $7.61 earnings per share (EPS) to beat the analysts' consensus estimate of $7.27 by $0.34.
The conference call for Humana Inc.'s latest earnings report can be listened to online.
The conference call transcript for Humana Inc.'s latest earnings report can be read online.
Humana Inc. (:HUM) has a recorded annual revenue of $129.66 B.
Humana Inc. (:HUM) has a recorded net income of $1.19 B.Humana Inc. has generated $9.87 earnings per share over the last four quarters.
Humana Inc. (:HUM) has a price-to-earnings ratio of 35.57 and price/earnings-to-growth ratio is -1.92.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED